targets, mechanism, and disease: biomarker development
Published 10 years ago • 18K plays • Length 2:46Download video MP4
Download video MP3
Similar videos
-
4:57
oncology biomarker development at genentech
-
5:50
understanding biomarkers
-
35:43
biomarkers & biomarker development
-
2:05
what are biomarkers and why are they important?
-
2:20
biomarkers and surrogate endpoints in drug development
-
5:26
what are biomarkers? how doctors personalize your healthcare | gi society
-
42:53
biomarkers in cancer immunotherapy: how much do they matter?
-
2:49
what are biomarkers?
-
15:26
optical sensing for digital biomarker development — jessilyn dunn | duke fip
-
2:55
designing tools for treatment: device development
-
2:39
making biomarker development successful
-
7:26
the role of consortia in biomarker development and qualification
-
5:47
how biomarkers can improve the drug development process
-
4:32
polina mamoshina, head of biomarker development, insilico, "projects scleroderma & raynauds uk"
-
21:18
s1e07: biomarkers and big data
-
17:14
biomarker and treatment development in movement disorders
-
2:18
biomarkers | technology that is changing neuroscience
-
19:36
#nihheal: pain clinical endpoints — biomarkers
-
5:47
mass spectrometry-based peptidomics for biomarker discovery
-
1:01:41
open stage webinar: biomarker development and validation
-
25:06
evolving landscape of targeted therapies | dr. lizza hendriks